Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Large-Scale Investment of Baxter/Baxalta in Austria

The American pharmaceutical and biotechology giant Baxter is investing EUR 138 million in Krems, Austria under its new name of Baxalta. The production facility in Krems will be expanded and modernized, creating 100 new jobs.   

The American pharmaceutical group Baxter is divided as of now into new separate publicly listed companies, one for its medical products and the other for its bioscience operations. The biotech division will be called Baxalta effective immediately. The Austrian plants in Krems and Orth/Donau both fully belong to the new biotech company Baxalta.  

The project which was announced calls for a blood clotting drug to be produced in Krems starting in 2018. “Over the past years we have had good experience with our production plant in Krems. Not only do we find very well trained employees here, but above all the possibility to partner with IMC University of Applied Sciences Krems and other specific facilities provides many advantages. For this reason, last year we reached an agreement to cooperate with IMC on research projects”, says Michael Heinrich of Baxalta, justifying the decision.  

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us at: “Austrian Business Circle”

    03.09.2018, St. Petersburg, Russia

  • Meet us at: Turkmenistan - Heart of the Great Silk Road

    05./06.09.2018, Hotel Savoyen Vienna, Rennweg 16, 1030 Vienna

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These
features are particularly important for a research-based company such as
Boehringer Ingelheim. Furthermore, Vienna is a city with a good research
infrastructure and a high quality of life, and is thus also an interesting place
for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

Chemical bonding simulated with a quantum computer

An international research group has carried out the world’s first quantum-chemical simulation on an ion-trapped quantum computer.

From Mixed Reality to Smart Factory – Austria Shapes the Digital Future of Work

New types of technologies are revolutionizing everyday work in the industrial sector. Methods and processes of industrial production in the future are being re-modelled in digital pilot factories. Austria has long been one of the most important providers of impetus in this dawning industrial age.

More news All blog posts